Mostafa Adam S.
SEC insider (Form 3/4/5 filer). CIK 0001738081. Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2025. Located in BOSTON, MA.
Companies Mostafa Adam S. has filed insider reports for
- X4 Pharmaceuticals, Inc (XFOR): Officer, Chief Financial Officer
Mostafa Adam S.
CIK: 0001738081
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XFOR
X4 Pharmaceuticals, Inc
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 12, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect850K shares- - Jan 24, 2025XFOR
X4 Pharmaceuticals, Inc
SaleDirect74.8K shares at avg. $0.45$34K - Jan 23, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect74.8K shares- - Oct 7, 2024XFOR
X4 Pharmaceuticals, Inc
SaleDirect230.6K shares at avg. $0.55$127K - Oct 4, 2024XFOR
X4 Pharmaceuticals, Inc
AwardDirect230.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 850,000 | - | - | Direct |
| Jan 24, 2025 | XFOR X4 Pharmaceuticals, Inc | Sale | 74,773 | $0.45 | $33,947 | Direct |
| Jan 23, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 74,773 | - | $0 | Direct |
| Oct 7, 2024 | XFOR X4 Pharmaceuticals, Inc | Sale | 230,645 | $0.55 | $126,901 | Direct |
| Oct 4, 2024 | XFOR X4 Pharmaceuticals, Inc | Award | 230,645 | - | $0 | Direct |
1-5 of 5 transactions